Session Tracksหัวข้อหลักของการประชุม

This track will explore advanced techniques and methodologies for the precise localization of human tumors. Emphasis will be placed on imaging technologies and their integration with clinical practices.

This session will focus on the biochemical and molecular pathways that drive cancer progression. Discussions will include the role of signaling pathways and their implications for targeted therapies.

This track aims to bridge the gap between laboratory research and clinical application in oncology. It will highlight successful case studies and innovative strategies in translational research.

This session will cover the latest advancements in clinical trial design and drug discovery processes. Participants will discuss challenges and opportunities in bringing new oncology therapies to market.

This track will delve into the application of statistical methods in biomedical research, particularly in oncology. It will address the importance of biostatistics in data analysis and interpretation.

This session will showcase cutting-edge biotechnological advancements that are transforming cancer treatment. Topics will include gene therapy, immunotherapy, and personalized medicine.

This track will explore the role of functional genomics in understanding cancer biology. Discussions will focus on how genomic data can inform therapeutic strategies and patient outcomes.

This session will address the unique challenges faced in the field of pediatric oncology. It will highlight recent advancements in treatment protocols and supportive care for young patients.

This track will focus on the latest research and clinical practices in gynaecological oncology. Emphasis will be placed on early detection, treatment modalities, and patient management.

This session will examine the clinical pathophysiological aspects of cancer. Discussions will include the interplay between cancer biology and clinical manifestations.

This track will address the ethical considerations and policy implications surrounding biomedical research in oncology. It will foster discussions on responsible research practices and patient rights.